EFFECTS OF SAPROPTERIN ON PORTAL AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION: A BICENTRIC DOUBLE-BLIND PLACEBO CONTROLLED STUDY

Trial Profile

EFFECTS OF SAPROPTERIN ON PORTAL AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION: A BICENTRIC DOUBLE-BLIND PLACEBO CONTROLLED STUDY

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs Sapropterin (Primary)
  • Indications Portal hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 05 May 2014 New trial record
    • 09 Apr 2014 Results presented at the 49th Annual Meeting of the European Association for the Study of the Liver.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top